Lucid Capital Markets Starts Turn Therapeutics (TTRX) at Buy Sep 24, 2026 06:13AM
WBB Securities Downgrades Turn Therapeutics (TTRX) to Sell Sep 14, 2026 09:28AM
Turn Therapeutics publishes GX-03 skin inflammation study in mice Aug 20, 2026 08:04AM
Ladenburg Thalmann Starts Turn Therapeutics (TTRX) at Buy Jul 20, 2026 06:46AM
Turn Therapeutics publishes study showing GX-03 reduces skin inflammation May 27, 2026 08:05AM


May 18, 2026 08:05AM Turn Therapeutics hires former FDA chief Hahn as clinical lead
May 11, 2026 04:55PM Turn Therapeutics Inc. (TTRX) Reports Q1 Loss of $0.03
Mar 24, 2026 08:01AM Turn Therapeutics secures up to $25 million loan from Avenue Capital
Jan 12, 2026 08:07AM Turn Therapeutics adds board member, expands vaccine pipeline
Dec 29, 2025 07:05AM D. Boral Capital Starts Turn Therapeutics (TTRX) at Buy
Oct 9, 2025 04:18PM Turn Therapeutics (TTRX) files for 7M share offering by selling stockholders